Compo-Q: New small molecules for the treatment of prion and neurodegenerative diseases(e.g. Alzheimer’s disease)

Scientists at the University of Duesseldorf and the University of Erlangen have developed new small molecules which can be used for the treatment of diseases characterized by the presence of misfolded proteins. Examples for such medical conditions are prion diseases, e.g. CJD, as well as neurodegenerative (e.g. Alzheimer’s disease) or neuropsychiatric diseases. Compo-Q have a structural relationship to quinacrine which is considered to be one of the most promising candidate for the clinical therapy of prion diseases. In Compo-Q the “modified quinacrine” is covalently linked to a derivative of another substance which has been proven effective against prion diseases in vitro.

Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 0

Contact
Dipl.-Ing. Alfred Schillert

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Digital ICTM Conference 2022

Achieving climate targets in turbomachinery engineering through digitization. Manufacturers and suppliers of engines and stationary turbomachinery have long recognized that the overriding goals of conserving resources and reducing emissions can…

Creating a reference map to explore the electronic device mimicking brain activity

Maps are essential for exploring trackless wilderness or vast expanses of ocean. The same is true for scientific studies that try to open up new fields and develop brand-new devices….

Arase satellite uncovers coupling between plasma waves and charged particles in Geospace

Scientists unravel a bit more of the mystery underlying how wave-particle interactions generate other plasma waves in Geospace. In a new study published in Physical Review Letters, researchers from Japan…

Partners & Sponsors